Appellate tribunal rules medicines not P&P, relieves duty liability. Apex Court precedent followed. The New Delhi appellate tribunal ruled in favor of the appellant, determining that the medicines in question were not categorized as P&P medicines, ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
The New Delhi appellate tribunal ruled in favor of the appellant, determining that the medicines in question were not categorized as P&P medicines, thereby relieving them of duty liability. The decision was based on a precedent set by the Apex Court, leading to the allowance of the appeals and setting aside of the impugned orders.
The appellate tribunal in New Delhi considered whether medicines manufactured by the appellant are P&P Medicines. The medicines were categorized as P&P medicine due to labels containing the manufacturer's name, leading to duty liability. Following a precedent set by the Apex Court, it was ruled that the appellant's medicines were not P&P medicine, and they are not liable for duty. The appeals were allowed, and the impugned orders were set aside.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.